vs

Side-by-side financial comparison of DILLARD'S, INC. (DDS) and Eastman Chemical Company (EMN). Click either name above to swap in a different company.

Eastman Chemical Company is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× DILLARD'S, INC.). DILLARD'S, INC. runs the higher net margin — 8.8% vs 5.3%, a 3.5% gap on every dollar of revenue. On growth, DILLARD'S, INC. posted the faster year-over-year revenue change (2.9% vs -13.8%). Over the past eight quarters, Eastman Chemical Company's revenue compounded faster (-8.6% CAGR vs -16.9%).

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.

DDS vs EMN — Head-to-Head

Bigger by revenue
EMN
EMN
1.3× larger
EMN
$2.0B
$1.5B
DDS
Growing faster (revenue YoY)
DDS
DDS
+16.8% gap
DDS
2.9%
-13.8%
EMN
Higher net margin
DDS
DDS
3.5% more per $
DDS
8.8%
5.3%
EMN
Faster 2-yr revenue CAGR
EMN
EMN
Annualised
EMN
-8.6%
-16.9%
DDS

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
DDS
DDS
EMN
EMN
Revenue
$1.5B
$2.0B
Net Profit
$129.8M
$105.0M
Gross Margin
43.4%
17.1%
Operating Margin
11.5%
Net Margin
8.8%
5.3%
Revenue YoY
2.9%
-13.8%
Net Profit YoY
4.2%
-42.3%
EPS (diluted)
$8.31
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDS
DDS
EMN
EMN
Q1 26
$2.0B
Q4 25
$1.5B
$2.0B
Q3 25
$1.5B
$2.2B
Q2 25
$1.5B
$2.3B
Q1 25
$2.0B
$2.3B
Q4 24
$1.4B
$2.2B
Q3 24
$1.5B
$2.5B
Q2 24
$1.5B
$2.4B
Net Profit
DDS
DDS
EMN
EMN
Q1 26
$105.0M
Q4 25
$129.8M
$105.0M
Q3 25
$72.8M
$47.0M
Q2 25
$163.8M
$140.0M
Q1 25
$214.4M
$182.0M
Q4 24
$124.6M
$330.0M
Q3 24
$74.5M
$180.0M
Q2 24
$180.0M
$230.0M
Gross Margin
DDS
DDS
EMN
EMN
Q1 26
17.1%
Q4 25
43.4%
17.1%
Q3 25
36.6%
19.7%
Q2 25
43.9%
22.1%
Q1 25
34.9%
24.8%
Q4 24
42.6%
24.7%
Q3 24
37.6%
24.6%
Q2 24
44.6%
25.3%
Operating Margin
DDS
DDS
EMN
EMN
Q1 26
Q4 25
11.5%
0.6%
Q3 25
6.2%
6.1%
Q2 25
14.0%
7.4%
Q1 25
11.7%
11.0%
Q4 24
11.4%
13.2%
Q3 24
6.5%
11.4%
Q2 24
15.2%
12.1%
Net Margin
DDS
DDS
EMN
EMN
Q1 26
5.3%
Q4 25
8.8%
5.3%
Q3 25
4.8%
2.1%
Q2 25
10.7%
6.1%
Q1 25
10.6%
7.9%
Q4 24
8.7%
14.7%
Q3 24
5.0%
7.3%
Q2 24
11.6%
9.7%
EPS (diluted)
DDS
DDS
EMN
EMN
Q1 26
$0.93
Q4 25
$8.31
$0.93
Q3 25
$4.66
$0.40
Q2 25
$10.39
$1.20
Q1 25
$13.41
$1.57
Q4 24
$7.73
$2.81
Q3 24
$4.59
$1.53
Q2 24
$11.09
$1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDS
DDS
EMN
EMN
Cash + ST InvestmentsLiquidity on hand
$1.1B
$566.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.0B
$6.0B
Total Assets
$4.3B
$14.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDS
DDS
EMN
EMN
Q1 26
$566.0M
Q4 25
$1.1B
$566.0M
Q3 25
$1.0B
Q2 25
$900.5M
Q1 25
$717.9M
Q4 24
$980.4M
$837.0M
Q3 24
$946.7M
Q2 24
$817.8M
Stockholders' Equity
DDS
DDS
EMN
EMN
Q1 26
$6.0B
Q4 25
$2.0B
$6.0B
Q3 25
$1.9B
$5.8B
Q2 25
$1.9B
$5.8B
Q1 25
$1.8B
$5.9B
Q4 24
$2.0B
$5.8B
Q3 24
$1.9B
$5.7B
Q2 24
$1.9B
$5.6B
Total Assets
DDS
DDS
EMN
EMN
Q1 26
$14.9B
Q4 25
$4.3B
$14.9B
Q3 25
$3.7B
$15.0B
Q2 25
$3.9B
$15.2B
Q1 25
$3.5B
$15.0B
Q4 24
$4.1B
$15.2B
Q3 24
$3.7B
$15.1B
Q2 24
$3.9B
$14.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDS
DDS
EMN
EMN
Operating Cash FlowLast quarter
$186.5M
Free Cash FlowOCF − Capex
$156.2M
FCF MarginFCF / Revenue
10.6%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
1.44×
TTM Free Cash FlowTrailing 4 quarters
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDS
DDS
EMN
EMN
Q1 26
Q4 25
$186.5M
$502.0M
Q3 25
$86.8M
$402.0M
Q2 25
$232.6M
$233.0M
Q1 25
$364.7M
$-167.0M
Q4 24
$173.5M
$540.0M
Q3 24
$-68.4M
$396.0M
Q2 24
$244.4M
$367.0M
Free Cash Flow
DDS
DDS
EMN
EMN
Q1 26
Q4 25
$156.2M
$390.0M
Q3 25
$60.1M
$265.0M
Q2 25
$215.8M
$83.0M
Q1 25
$349.3M
$-314.0M
Q4 24
$145.4M
$361.0M
Q3 24
$-94.3M
$276.0M
Q2 24
$209.2M
$252.0M
FCF Margin
DDS
DDS
EMN
EMN
Q1 26
Q4 25
10.6%
19.8%
Q3 25
4.0%
12.0%
Q2 25
14.1%
3.6%
Q1 25
17.3%
-13.7%
Q4 24
10.2%
16.1%
Q3 24
-6.3%
11.2%
Q2 24
13.5%
10.7%
Capex Intensity
DDS
DDS
EMN
EMN
Q1 26
Q4 25
2.1%
5.7%
Q3 25
1.8%
6.2%
Q2 25
1.1%
6.6%
Q1 25
0.8%
6.4%
Q4 24
2.0%
8.0%
Q3 24
1.7%
4.9%
Q2 24
2.3%
4.9%
Cash Conversion
DDS
DDS
EMN
EMN
Q1 26
Q4 25
1.44×
4.78×
Q3 25
1.19×
8.55×
Q2 25
1.42×
1.66×
Q1 25
1.70×
-0.92×
Q4 24
1.39×
1.64×
Q3 24
-0.92×
2.20×
Q2 24
1.36×
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons